ici 170809 has been researched along with ici 169369 in 3 studies
| Studies (ici 170809) | Trials (ici 170809) | Recent Studies (post-2010) (ici 170809) | Studies (ici 169369) | Trials (ici 169369) | Recent Studies (post-2010) (ici 169369) |
|---|---|---|---|---|---|
| 14 | 1 | 0 | 31 | 4 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, T; Edvinsson, L; Eriksen, K; Jansen, I | 1 |
| Frenken, M; Kaumann, AJ | 1 |
| Blackburn, TP; Cox, B; Echevarria, E; Pastel, RH; Tortella, FC | 1 |
3 other study(ies) available for ici 170809 and ici 169369
| Article | Year |
|---|---|
5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
Topics: Cerebral Arteries; Humans; In Vitro Techniques; Methysergide; Muscle, Smooth, Vascular; Quinolines; Receptors, Serotonin; Serotonin Antagonists; Temporal Arteries; Vasoconstriction | 1991 |
Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
Topics: Animals; Cattle; Dose-Response Relationship, Drug; In Vitro Techniques; Methylation; Methysergide; Quinolines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Vasoconstriction | 1989 |
Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat.
Topics: Animals; Electroencephalography; Electromyography; Male; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Sleep; Sleep, REM | 1993 |